$18.05
0.72%
Downside
Day's Volatility :2.4%
Upside
1.69%
2.83%
Downside
52 Weeks Volatility :41.82%
Upside
40.13%
Period | Privia Health Group, Inc. | |
---|---|---|
3 Months | -17.18% | |
6 Months | -18.96% | |
1 Year | -31.46% | |
3 Years | -47.97% |
Market Capitalization | 2.1B |
Book Value | $4.75 |
Earnings Per Share (EPS) | 0.19 |
PE Ratio | 95.16 |
Wall Street Target Price | 27.82 |
Profit Margin | 1.39% |
Operating Margin TTM | 0.32% |
Return On Assets TTM | 1.44% |
Return On Equity TTM | 3.73% |
Revenue TTM | 1.7B |
Revenue Per Share TTM | 14.2 |
Quarterly Revenue Growth YOY | 21.0% |
Gross Profit TTM | 134.8M |
EBITDA | 27.2M |
Diluted Eps TTM | 0.19 |
Quarterly Earnings Growth YOY | -0.83 |
EPS Estimate Current Year | 0.24 |
EPS Estimate Next Year | 0.33 |
EPS Estimate Current Quarter | 0.04 |
EPS Estimate Next Quarter | 0.06 |
What analysts predicted
Upside of 54.13%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 657.6M | - |
Net Income | -3.0M | - |
Net Profit Margin | -0.46% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 786.4M | ↑ 19.58% |
Net Income | 8.2M | ↓ 370.83% |
Net Profit Margin | 1.05% | ↑ 1.51% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 817.1M | ↑ 3.91% |
Net Income | 31.2M | ↑ 278.99% |
Net Profit Margin | 3.82% | ↑ 2.77% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 966.2M | ↑ 18.25% |
Net Income | -190.6M | ↓ 710.19% |
Net Profit Margin | -19.73% | ↓ 23.55% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 40.41% |
Net Income | -12.1M | ↓ 93.67% |
Net Profit Margin | -0.89% | ↑ 18.84% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.7B | ↑ 22.19% |
Net Income | 23.1M | ↓ 291.3% |
Net Profit Margin | 1.39% | ↑ 2.28% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 342.9M | ↑ 2.19% |
Net Income | 556.0K | ↓ 104.89% |
Net Profit Margin | 0.16% | ↑ 3.55% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 364.4M | ↑ 6.28% |
Net Income | 17.8M | ↑ 3097.12% |
Net Profit Margin | 4.88% | ↑ 4.72% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 386.3M | ↑ 6.0% |
Net Income | 7.3M | ↓ 58.8% |
Net Profit Margin | 1.9% | ↓ 2.98% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 413.4M | ↑ 7.01% |
Net Income | 7.3M | ↓ 0.68% |
Net Profit Margin | 1.76% | ↓ 0.14% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 417.3M | ↑ 0.95% |
Net Income | 5.6M | ↓ 22.42% |
Net Profit Margin | 1.35% | ↓ 0.41% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 440.8M | ↑ 5.64% |
Net Income | 2.8M | ↓ 49.71% |
Net Profit Margin | 0.64% | ↓ 0.71% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 270.2M | - |
Total Liabilities | 162.7M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 329.0M | ↑ 21.75% |
Total Liabilities | 185.3M | ↑ 13.87% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 686.4M | ↑ 108.64% |
Total Liabilities | 236.2M | ↑ 27.45% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 792.8M | ↑ 15.51% |
Total Liabilities | 273.8M | ↑ 15.91% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 999.9M | ↑ 26.12% |
Total Liabilities | 392.5M | ↑ 43.38% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 807.8M | ↑ 8.43% |
Total Liabilities | 316.7M | ↑ 13.97% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 792.8M | ↓ 1.85% |
Total Liabilities | 273.8M | ↓ 13.56% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 875.3M | ↑ 10.41% |
Total Liabilities | 318.8M | ↑ 16.46% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 937.6M | ↑ 7.11% |
Total Liabilities | 366.3M | ↑ 14.88% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 992.3M | ↑ 5.84% |
Total Liabilities | 401.3M | ↑ 9.56% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 999.9M | ↑ 0.76% |
Total Liabilities | 392.5M | ↓ 2.18% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.2M | - |
Investing Cash Flow | -165.0K | - |
Financing Cash Flow | 15.4M | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 24.4M | ↑ 364.05% |
Investing Cash Flow | -5.7M | ↑ 3360.0% |
Financing Cash Flow | -10.9M | ↓ 170.77% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 38.9M | ↑ 59.66% |
Investing Cash Flow | -380.0K | ↓ 93.34% |
Financing Cash Flow | -767.0K | ↓ 92.94% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 55.1M | ↑ 41.57% |
Investing Cash Flow | -32.8M | ↑ 8525.0% |
Financing Cash Flow | 213.7M | ↓ 27956.71% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 47.2M | ↓ 14.28% |
Investing Cash Flow | -104.0K | ↓ 99.68% |
Financing Cash Flow | -19.7M | ↓ 109.21% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 16.1M | ↑ 123.71% |
Investing Cash Flow | -16.0K | ↓ 58.97% |
Financing Cash Flow | 8.6M | ↓ 127.74% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 29.2M | ↑ 80.58% |
Investing Cash Flow | -15.0K | ↓ 6.25% |
Financing Cash Flow | 2.0M | ↓ 77.18% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -13.4M | ↓ 145.91% |
Investing Cash Flow | -24.9M | ↑ 165606.67% |
Financing Cash Flow | 1.5M | ↓ 24.53% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.6M | ↓ 156.84% |
Investing Cash Flow | -72.0K | ↓ 99.71% |
Financing Cash Flow | -819.0K | ↓ 155.45% |
Sell
Neutral
Buy
Privia Health Group, Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Privia Health Group, Inc. | -7.8% | -18.96% | -31.46% | -47.97% | -47.97% |
Solventum Corp | -10.17% | -9.99% | -10.17% | -9.99% | -10.17% |
Veeva Systems Inc. | -13.91% | 1.67% | 6.45% | -28.92% | 47.98% |
Ge Healthcare Technologies Inc. | -4.5% | 32.04% | -3.96% | 39.68% | 39.38% |
Healthequity Inc | 1.58% | 12.43% | 43.7% | 10.01% | 17.2% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Privia Health Group, Inc. | 93.79 | 95.16 | NA | 0.24 | 0.04 | 0.01 | NA | 4.75 |
Solventum Corp | NA | NA | NA | 0.0 | 0.12 | 0.08 | NA | NA |
Veeva Systems Inc. | 62.16 | 62.16 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 27.85 | 27.85 | 20.11 | 4.3 | 0.19 | 0.06 | 0.0 | 15.67 |
Healthequity Inc | 124.77 | 124.77 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Privia Health Group, Inc. | Buy | $2.1B | -47.97% | 93.79 | 1.39% |
Solventum Corp | NA | $11.7B | -10.17% | NA | 16.42% |
Veeva Systems Inc. | Buy | $32.2B | 47.98% | 62.16 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $38.6B | 39.38% | 27.85 | 8.02% |
Healthequity Inc | Buy | $6.9B | 17.2% | 124.77 | 5.57% |
BlackRock Inc
FMR Inc
Vanguard Group Inc
Durable Capital Partners LP
T. Rowe Price Investment Management,Inc.
Riverbridge Partners LLC
we believe this is the most exciting time in history to be involved in healthcare. our team is leading transformative change; rapidly evolving the system from “sick care” to “well care.” we think life’s too short not to do something with passion, and here at privia we’re doing something that makes a tangible difference. we look for people with that passion. people who want to experience life to the fullest. people who are curious, resourceful, hard working, and tenacious. people who disdain the status quo. our culture is made up of people who look at the world and see opportunity, and who aren’t afraid to dive right in, experience life, and make that opportunity happen.
Organization | Privia Health Group, Inc. |
Employees | 1102 |
CEO | Mr. Parth Mehrotra |
Industry | Healthcare |
Krystal Biotech Inc
$18.05
-0.17%
Amn Healthcare Services Inc.
$18.05
-0.17%
Option Care Health Inc
$18.05
-0.17%
Vaxcyte Inc
$18.05
-0.17%
Xenon Pharmaceuticals Inc
$18.05
-0.17%
Tenet Healthcare Corp.
$18.05
-0.17%
Hutchison China Meditech Limited
$18.05
-0.17%
Radnet Inc
$18.05
-0.17%
Patterson Companies, Inc.
$18.05
-0.17%